Bimzelx 320 MG/2 ML autoinject 2ML
Ended Awarded
- Contract number
- SPE2DR26F8ZMK
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $34,485
Award facts
- Contract value 100% obligated
- $34,484.68 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $34,484.68 to AmerisourceBergen Drug Corp for BIMZELX 320 MG/2 ML auto-injector units on November 13, 2025, with completion scheduled for November 14, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation, performed at the awardee's corporate headquarters in Conshohocken, Pennsylvania. BIMZELX is a prescription biologic medication used in the treatment of plaque psoriasis and other inflammatory conditions, and this delivery order reflects the federal government's procurement of this specialized pharmaceutical product for military healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications, biologics, vaccines, and medical supplies to support military healthcare programs worldwide. AmerisourceBergen, a major pharmaceutical distributor headquartered in Pennsylvania, has demonstrated substantial capacity to fulfill federal medical procurement requirements across multiple therapeutic domains and maintains a significant portfolio of competitively awarded contracts with the Defense Logistics Agency for critical medical supply chain support.
Quick answers
Who was awarded contract SPE2DR26F8ZMK?
SPE2DR26F8ZMK was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 13, 2025.
How much is contract SPE2DR26F8ZMK worth?
The government has obligated $34,485 on SPE2DR26F8ZMK.
Is contract SPE2DR26F8ZMK an order under another contract?
Yes. SPE2DR26F8ZMK is a delivery order under SPE2DR25D1017, an indefinite delivery contract.
Was contract SPE2DR26F8ZMK competed?
The extent of competition for SPE2DR26F8ZMK was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award